Wall Street analysts expect Encompass Health Corp (NYSE:EHC) to post earnings per share of $0.84 for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Encompass Health’s earnings, with the lowest EPS estimate coming in at $0.78 and the highest estimate coming in at $0.96. Encompass Health posted earnings of $0.80 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 5%. The company is scheduled to announce its next earnings report after the market closes on Thursday, February 6th.
According to Zacks, analysts expect that Encompass Health will report full year earnings of $3.87 per share for the current year, with EPS estimates ranging from $3.83 to $4.00. For the next fiscal year, analysts anticipate that the firm will report earnings of $3.70 per share, with EPS estimates ranging from $3.57 to $3.93. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Encompass Health.
Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.89 by $0.04. Encompass Health had a return on equity of 23.89% and a net margin of 7.07%. The firm had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.16 billion.
A number of equities analysts have issued reports on EHC shares. ValuEngine cut Encompass Health from a “buy” rating to a “hold” rating in a report on Wednesday, October 30th. BMO Capital Markets raised their target price on Encompass Health from $85.00 to $88.00 and gave the stock an “outperform” rating in a report on Tuesday. UBS Group raised their target price on Encompass Health from $80.00 to $87.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Finally, Credit Suisse Group raised their target price on Encompass Health from $77.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $79.83.
EHC traded down $0.79 during midday trading on Friday, reaching $79.46. 710,684 shares of the company were exchanged, compared to its average volume of 672,408. The company has a debt-to-equity ratio of 1.94, a quick ratio of 0.97 and a current ratio of 0.97. Encompass Health has a one year low of $56.74 and a one year high of $80.72. The stock has a market capitalization of $7.91 billion, a P/E ratio of 24.75, a PEG ratio of 2.49 and a beta of 0.82. The stock’s 50-day simple moving average is $70.94 and its 200 day simple moving average is $66.28.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend was Tuesday, December 31st. Encompass Health’s dividend payout ratio (DPR) is presently 30.85%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Story: How can investors find ex-dividend dates?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.